menu search

Eli lilly stock starts fresh week on front foot after rival alzheimer trial fails

Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clini...

November 14, 2022, 10:03 am

Biogen shares jump 4.7% premarket on hopes for its alzheimer's treatment lecanemab

Biogen Inc. shares BIIB, -0.43% rose 4.7% in premarket trade Monday, after MorphoSys and partner Roche said a trial of a treatment for Alzheimer's dis...

November 14, 2022, 6:41 am

Morphosys shares plunge after partner roche says alzheimer's drug trials didn't meet goals

German-listed shares of MorphoSys MOR, -31.96% MOR, +2.44% lost a third of their value on Monday after its partner Roche said an Alzheimer drug trial ...

November 14, 2022, 5:22 am

Roche's alzheimer's drug fails to meet goal in long awaited trial

Roche said its Alzheimer's drug candidate could not clearly be shown to slow dementia progression in tw...

November 14, 2022, 1:13 am

Next avenue: these simple food choices could reduce your risk of dementia

Recent research has found an association between ultra-processed foods and dementia. Here’s how to spot and avoid them, even when traveling and eati...

November 12, 2022, 3:50 pm

Bioxcel therapeutics: bxcl501 for acute agitation in patients with dementia and alzheimer's - a great asset

BioXcel is currently conducting phase II and III trials of BXCL501 to treat acute agitation in patients with d...

July 19, 2022, 5:02 am

Hoth therapeutics shares surge on encouraging preclinical data from alzheimer's program

Hoth Therapeutics Inc (NASDAQ: HOTH) has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's dis...

July 12, 2022, 2:37 pm

Mgc pharmaceuticals agrees european distribution deal for cannabinoid treatments

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has signed an exclusive distribution for the UK and certain EU countries for its proprietary can...

April 5, 2022, 3:00 am

Why longeveron shares are surging today

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing ...

March 31, 2022, 10:06 am

Anavex life sciences highlights biomarker data from parkinson's disease dementia at international conference

Anavex Life Sciences Corp (NASDAQ: AVXL) has announced the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson's ...

March 15, 2022, 12:20 pm

Denali (dnli) begins frontotemporal dementia-granulin study

Denali (DNLI) starts an early-stage study of DNL593 for treating frontotemporal dementia (FTD) due to m...

March 10, 2022, 2:17 pm

Mgc pharmaceuticals records strongest ever quarterly sales; cognicann phase ii trial delayed

MGC Pharmaceutical Ltd said it achieved its strongest quarterly sales to date in the three months to end-December, driven by its COVID-19 treatment Ar...

January 31, 2022, 6:21 am

Mgc pharmaceuticals records strongest ever quarterly sales; cognicann phase ii trial delayed

MGC Pharmaceutical Ltd said it achieved its strongest quarterly sales to date in the three months to end-December, driven by its COVID-19 treatment Ar...

January 31, 2022, 6:21 am

Mgc pharmaceuticals records strongest ever quarterly sales; cognicann phase ii trial delayed

MGC Pharmaceutical Ltd said it achieved its strongest quarterly sales to date in the three months to end-December, driven by its COVID-19 treatment Ar...

January 31, 2022, 6:21 am


Search within

Pages Search Results: